全文获取类型
收费全文 | 10053篇 |
免费 | 876篇 |
国内免费 | 4篇 |
专业分类
10933篇 |
出版年
2023年 | 67篇 |
2022年 | 155篇 |
2021年 | 297篇 |
2020年 | 162篇 |
2019年 | 195篇 |
2018年 | 240篇 |
2017年 | 185篇 |
2016年 | 392篇 |
2015年 | 586篇 |
2014年 | 596篇 |
2013年 | 676篇 |
2012年 | 884篇 |
2011年 | 773篇 |
2010年 | 462篇 |
2009年 | 420篇 |
2008年 | 594篇 |
2007年 | 540篇 |
2006年 | 456篇 |
2005年 | 373篇 |
2004年 | 364篇 |
2003年 | 334篇 |
2002年 | 332篇 |
2001年 | 122篇 |
2000年 | 104篇 |
1999年 | 100篇 |
1998年 | 96篇 |
1997年 | 51篇 |
1996年 | 46篇 |
1995年 | 60篇 |
1994年 | 44篇 |
1993年 | 38篇 |
1992年 | 65篇 |
1991年 | 75篇 |
1990年 | 76篇 |
1989年 | 75篇 |
1988年 | 56篇 |
1987年 | 36篇 |
1986年 | 42篇 |
1985年 | 42篇 |
1984年 | 43篇 |
1983年 | 52篇 |
1982年 | 41篇 |
1981年 | 44篇 |
1980年 | 30篇 |
1979年 | 41篇 |
1978年 | 46篇 |
1977年 | 27篇 |
1974年 | 27篇 |
1973年 | 29篇 |
1970年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
42.
K. S. Hong T. E. Richter J. L. Bennetzen S. H. Hulbert 《Molecular & general genetics : MGG》1993,239(1-2):115-121
Rp1 is a disease resistance complex and is the terminal morphological marker on the short arm of maize chromosome 10. Several restriction fragment length polymorphisms (RFLPs), which map within 5 map units of Rp1, were examined to determine if they are also complex in structure. Two RFLP loci, which mapped distally to Rp1, BNL3.04 and PIO200075, existed in a single copy in all maize lines examined. These two loci cosegregated perfectly in 130 test cross progeny. Two RFLP loci that map proximally to Rp1 had unusual structures, which have not yet been reported for maize RFLPs; the loci were complex, with variable numbers of copies in different maize lines. One of the loci, NPI285, occasionally recombined in meiosis to yield changes in the number of copies of sequences homologous to the probe. The other proximal locus, detected by the probes NPI422, KSU3, and KSU4, was relatively stable in meiosis and no changes in the number of restriction fragments were observed. The similarity in map position between Rp1 and the complex RFLP loci indicate there may be genomic areas where variable numbers of repeated sequences are common. The structure of these complex loci may provide insight into the structure and evolution of Rp1. 相似文献
43.
The HLA class II sequences included in this compilation are taken from publications listed in the papers: Nomenclature for factors of the HLA system, 1989, Nomenclature for factors of the HLA system, 1990, and Nomenclature for factors of the HLA system, 1991 (WHO Nomenclature Committee 1990, 1991, 1992). Where discrepancies have arisen between reported sequences, the original authors have been contacted where possible, and necessary amendments to published sequences have been incorporated into this alignment. Future sequencing may identify errors in this list, and we would welcome any evidence that helps to maintain the accuracy of this compilation. In the sequence alignments, identity between residues is indicated by a hyphen (-), an unavailable sequence is indicated by an asterisk (*), and gaps in the sequence are inserted to maintain the alignment between different alleles showing variation in amino acid number.
Correspondence to: S. G. E. Marsh. 相似文献
44.
Wagner U. Reinsberg J. Schmidt S. Mallmann P. Schmolling J. Schultes B. Richter H. Biersack H. J. Krebs D. 《Cell biochemistry and biophysics》1994,24(1-3):237-242
Antibodies can be processed by the B- and T-cell systems and may lead to a selective activation of the immune system. The
network structure of the immune system implicates the possibility of a selective immunization by the activation of idiotypic
cascades.
In a retrospective analysis, patients with advanced ovarian carcinoma, who had received MAb, against the cancer-associated
antigen CA125 for diagnostic purposes, were analyzed for the production of anti-idiotypic antibodies, survival rate, and immunological
effects. Furthermore, we started a prospective and randomized study for ovarian cancer patients, using a different antigen,
TAG72, for the induction of idiotypic cascades.
Our first results on 58 patients with advanced ovarian carcinomas showed that the induction of anti-idiotypic-antibodies against
OC125 mimicking the TAA Class III CA125 leads to a prolongation of the survival rate, and, in extended stages, to an induction
of antitumoral immunity, and that the induction of idiotypic cascades is also possible for different antigens like TAG72.
Summarizing the activation of idio-typic network cascades seems to be a very effective way of intervention in the immune system
of patients with advanced stages of ovarian carcinoma. A prospective study of the adjuvant approach seems to be necessary. 相似文献
45.
Jennifer D. Russell Sahra Svensson-Hoglund Jessika Luth Richter Carl Dalhammar Leonidas Milios 《Journal of Industrial Ecology》2023,27(3):845-855
Research into repair within the circular economy (CE) typically focuses on technical aspects of design, policy, and markets, and often assumes simplified conditions for the user/owner and the product system to explain the barriers to scaling repair activities. However, factors occurring at pre-use stages of the product's life cycle can significantly influence whether, and to what extent, repair is viable or possible, that is, warranty duration, after-sale service provision, and access to necessities. The passing of time can directly and indirectly affect the ability, difficulty, and thus, the likelihood of repair activities being performed at each stage of the product's life cycle. Drawing from the literature and applying inductive systems-thinking tools, we propose a framework for considering the “System of Repairability.” We delineate how the passing of time (temporal dimensions) affects one's ‘‘ability to repair,’’ as a product progresses through different life cycle phases (i.e., breakdown vs. repair vs. disposal), and the point(s) at which the repair is considered or attempted (i.e., year of usage). By integrating life cycle and temporal (time-based) dimensions into a broad System of Repairability framework, we clarify relevant interconnections, iterations, sequences, and timing of decision points, stakeholders, and necessary conditions to facilitate an outcome of successful repair at the individual level, and thus intervention strategies for scaling repair within CE. We discuss how a policy mix can address the life cycle of products and the repair system more holistically. We conclude with a future outlook on how temporal dimensions can inform policy strategies and future research. 相似文献
46.
47.
48.
R. Ashton Lavoie Jeffrey T. Zugates Andrew T. Cheeseman Matt A. Teten Srivatsan Ramesh Julia M. Freeman Summer Swango Jeremy Fitzpatrick Amod Joshi Bradley Hollers Zufan Debebe Tyler K. Lindgren Amber N. Kozak Vinay K. Kondeti Mary K. Bright Eric J. Yearley Alexander Tracy Jacob A. Irwin Michael Guerrero 《Biotechnology and bioengineering》2023,120(10):2953-2968
Adeno-associated virus-based gene therapies have demonstrated substantial therapeutic benefit for the treatment of genetic disorders. In manufacturing processes, viral capsids are produced with and without the encapsidated gene of interest. Capsids devoid of the gene of interest, or “empty” capsids, represent a product-related impurity. As a result, a robust and scalable method to enrich full capsids is crucial to provide patients with as much potentially active product as possible. Anion exchange chromatography has emerged as a highly utilized method for full capsid enrichment across many serotypes due to its ease of use, robustness, and scalability. However, achieving sufficient resolution between the full and empty capsids is not trivial. In this work, anion exchange chromatography was used to achieve empty and full capsid resolution for adeno-associated virus serotype 5. A salt gradient screen of multiple salts with varied valency and Hofmeister series properties was performed to determine optimal peak resolution and aggregate reduction. Dual salt effects were evaluated on the same product and process attributes to identify any synergies with the use of mixed ion gradients. The modified process provided as high as ≥75% AAV5 full capsids (≥3-fold enrichment based on the percent full in the feed stream) with near baseline separation of empty capsids and achieved an overall vector genome step yield of >65%. 相似文献
49.
50.
Yaoyu Ren Timo Danner Alexandra Moy Martin Finsterbusch Tanner Hamann Jan Dippell Till Fuchs Marius Müller Ricky Hoft André Weber Larry A. Curtiss Peter Zapol Matthew Klenk Anh T. Ngo Pallab Barai Brandon C. Wood Rongpei Shi Liwen F. Wan Tae Wook Heo Martin Engels Jagjit Nanda Felix H. Richter Arnulf Latz Venkat Srinivasan Jürgen Janek Jeff Sakamoto Eric D. Wachsman Dina Fattakhova-Rohlfing 《Liver Transplantation》2023,13(1):2201939
The garnet-type phase Li7La3Zr2O12 (LLZO) attracts significant attention as an oxide solid electrolyte to enable safe and robust solid-state batteries (SSBs) with potentially high energy density. However, while significant progress has been made in demonstrating compatibility with Li metal, integrating LLZO into composite cathodes remains a challenge. The current perspective focuses on the critical issues that need to be addressed to achieve the ultimate goal of an all-solid-state LLZO-based battery that delivers safety, durability, and pack-level performance characteristics that are unobtainable with state-of-the-art Li-ion batteries. This perspective complements existing reviews of solid/solid interfaces with more emphasis on understanding numerous homo- and heteroionic interfaces in a pure oxide-based SSB and the various phenomena that accompany the evolution of the chemical, electrochemical, structural, morphological, and mechanical properties of those interfaces during processing and operation. Finally, the insights gained from a comprehensive literature survey of LLZO–cathode interfaces are used to guide efforts for the development of LLZO-based SSBs. 相似文献